Cumberland Pharmaceuticals Inc.CPIXNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank79
3Y CAGR-25.3%
5Y CAGR+1.9%
Studio
Year-over-Year Change

Free cash flow yield

3Y CAGR
-25.3%/yr
Annual compound
5Y CAGR
+1.9%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20258.12%+441.8%
2024-2.38%-110.8%
202322.04%+13.2%
202219.47%+126.3%
20218.60%+16.6%
20207.38%+108.2%
20193.54%+386.3%
2018-1.24%+29.2%
2017-1.75%+3.1%
2016-1.80%-